Received Sep 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
redness and pain at the site; redness and pain at the site; stayed in bed with generalized muscle aches and fever for at least one full day.; stayed in bed with generalized muscle aches and fever for at least one full day.; This is a spontaneous report received from a Nurse. An elderly female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose 7, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "sulfa allergy" (unspecified if ongoing); "GI cramping" (unspecified if ongoing), notes: with cantaloupe and avocado. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (dose 1, single), for COVID-19 immunisation, reaction(s): "Generalized muscle aches", "fever", "Vaccination site erythema", "Vaccination site pain"; Bnt162b2 (dose 2, single), for COVID-19 immunisation, reaction(s): "Generalized muscle aches", "fever", "Vaccination site erythema", "Vaccination site pain"; Bnt162b2 (dose 3, single), for COVID-19 immunisation, reaction(s): "Generalized muscle aches", "fever", "Vaccination site erythema", "Vaccination site pain"; Bnt162b2 (dose 4, single), for COVID-19 immunisation, reaction(s): "Generalized muscle aches", "fever", "Vaccination site erythema", "Vaccination site pain"; Bnt162b2 (dose 5, single), for COVID-19 immunisation, reaction(s): "Generalized muscle aches", "fever", "Vaccination site erythema", "Vaccination site pain"; Bnt162b2 (dose 6, single), for COVID-19 immunisation, reaction(s): "Generalized muscle aches", "fever", "Vaccination site erythema", "Vaccination site pain". The following information was reported: INJECTION SITE ERYTHEMA (non-serious), INJECTION SITE PAIN (non-serious), outcome "unknown" and all described as "redness and pain at the site"; MYALGIA (non-serious), PYREXIA (non-serious), outcome "unknown" and all described as "stayed in bed with generalized muscle aches and fever for at least one full day.". Additional information: The pharmacist struggled to inject the contents of the syringe, and the reporter suspected that the vaccine never entered her body. After feeling the needle in her arm, she said, 'It's not going in.' The pharmacist proceeded to push against the patient's arm, to the extent that she had to rigidly tighten her upper body to stay upright in the chair during her odd "pushing" attempts. She never said that the contents of the syringe had gone in. She withdrew the syringe, wrote on some papers, and quickly dismissed her. After all seven previous Pfizer Covid-19 vaccinations, the reporter experienced redness and pain at the injection site and had to stay in bed with generalized muscle aches and a fever for at least one full day. However, after yesterday's vaccination, she has not experienced any pain at the injection site. She wonders why the practitioner had so much trouble after the needle was in. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500182329 same patient, different vaccine/event;
Medical History/Concurrent Conditions: Gastrointestinal cramps (with cantaloupe and avocado); Sulfonamide allergy